- Home
- CXAI vs LSTA Comparison
CXAI vs LSTA Comparison
Compare CXAI & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CXAI
- LSTA
- Stock Information
- Founded
- CXAI N/A
- LSTA 1980
- Country
- CXAI United States
- LSTA United States
- Employees
- CXAI N/A
- LSTA N/A
- Industry
- CXAI EDP Services
- LSTA Misc Health and Biotechnology Services
- Sector
- CXAI Technology
- LSTA Health Care
- Exchange
- CXAI Nasdaq
- LSTA Nasdaq
- Market Cap
- CXAI 22.4M
- LSTA 24.1M
- IPO Year
- CXAI N/A
- LSTA N/A
- Fundamental
- Price
- CXAI $1.00
- LSTA $2.91
- Analyst Decision
- CXAI
- LSTA Strong Buy
- Analyst Count
- CXAI 0
- LSTA 1
- Target Price
- CXAI N/A
- LSTA $15.00
- AVG Volume (30 Days)
- CXAI 493.4K
- LSTA 21.4K
- Earning Date
- CXAI 08-11-2025
- LSTA 08-11-2025
- Dividend Yield
- CXAI N/A
- LSTA N/A
- EPS Growth
- CXAI N/A
- LSTA N/A
- EPS
- CXAI N/A
- LSTA N/A
- Revenue
- CXAI $6,548,000.00
- LSTA $1,000,000.00
- Revenue This Year
- CXAI N/A
- LSTA N/A
- Revenue Next Year
- CXAI $60.00
- LSTA N/A
- P/E Ratio
- CXAI N/A
- LSTA N/A
- Revenue Growth
- CXAI N/A
- LSTA N/A
- 52 Week Low
- CXAI $0.76
- LSTA $1.87
- 52 Week High
- CXAI $3.76
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- CXAI 51.50
- LSTA 59.12
- Support Level
- CXAI $0.95
- LSTA $2.34
- Resistance Level
- CXAI $1.07
- LSTA $3.09
- Average True Range (ATR)
- CXAI 0.06
- LSTA 0.26
- MACD
- CXAI 0.01
- LSTA 0.02
- Stochastic Oscillator
- CXAI 61.36
- LSTA 76.00
About CXAI CXApp Inc.
CXApp Inc is a provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency. The company's flagship product, the CXAI Platform, provides a comprehensive suite of tools designed to empower employees and enable organizations to create smarter workplaces. The product's key components include CXAI Apps, CXAI BTS, and CXAI-VU. The company generates the majority of its revenue from Licenses.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.